These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3300530)

  • 1. Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
    Pangon B; Joly V; Vallois JM; Abel L; Buré A; Brion N; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Apr; 31(4):518-22. PubMed ID: 3300530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
    Joly V; Pangon B; Brion N; Vallois JM; Carbon C
    J Pharmacol Exp Ther; 1988 Aug; 246(2):695-700. PubMed ID: 3042958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.
    Joly V; Pangon B; Vallois JM; Abel L; Brion N; Bure A; Chau NP; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1632-9. PubMed ID: 3324957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
    Fantin B; Pangon B; Potel G; Caron F; Vallée E; Vallois JM; Mohler J; Buré A; Philippon A; Carbon C
    Antimicrob Agents Chemother; 1990 Apr; 34(4):581-6. PubMed ID: 2188586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.
    Fantin B; Pangon B; Potel G; Vallois JM; Caron F; Bure A; Carbon C
    Antimicrob Agents Chemother; 1989 May; 33(5):767-70. PubMed ID: 2665645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.
    Contrepois A; Vallois JM; Garaud JJ; Pangon B; Mohler J; Meulemans A; Carbon C
    J Antimicrob Chemother; 1986 Feb; 17(2):227-37. PubMed ID: 3516963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: renal clearance in rats and rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Aug; 34(8):1055-63. PubMed ID: 6274837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1476-85. PubMed ID: 6274834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.
    von Graevenitz A; Bucher C
    Infection; 1982; 10(5):293-8. PubMed ID: 6293976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.
    Korting HC
    Chemotherapy; 1984; 30(5):277-82. PubMed ID: 6092005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Todd PA
    Drugs; 1987 Aug; 34(2):188-221. PubMed ID: 3304966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D; Le Noc P; Le Noc D
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies on the transference of cephem-type antibiotics into bile and gallbladder tissues with special reference to cefotiam and cefmenoxime].
    Shiozaki H; Aeba S; Matsumoto H; Usui R; Totsuka S; Kusaba T; Mishima T; Hasegawa S; Iijima K; Okano A
    Jpn J Antibiot; 1986 Mar; 39(3):751-60. PubMed ID: 3461175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.
    Gavaldà J; López P; Martín T; Gomis X; Ramírez JL; Azuaje C; Almirante B; Pahissa A
    Antimicrob Agents Chemother; 2002 Feb; 46(2):378-84. PubMed ID: 11796345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.
    Caron F; Gutmann L; Bure A; Pangon B; Vallois JM; Pechinot A; Carbon C
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2070-4. PubMed ID: 2073099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
    Watanabe N; Katsu K; Moriyama M; Kitoh K
    Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.